[1] Baroni A, Paoletti I, Silvestri I, et al. Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis[J]. Br J Dematol, 2003, 148(3):424-33. [2] Zhang H, Satyamoorthy K, Herlyn M, et al. All-trans retinoic acid(atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells-a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution[J].Carcinogenesis, 2003, 24(2): 185-91. [3] Desai SH, Boskovic G, Eastham L, et al. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells[J]. Biochem Pharmacol, 2000, 59(10): 1265-75. [4] Emionite L, Galmozzi F, Raffo P, et al. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line[J]. Anticancer Res, 2003, 23(1A): 13 -9. [5] Darzynkiewicz Z, Juan G, Li X, et al. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis)[J].Cytometry, 1997, 27(1): 1-20. [6] Demary K, Wong L, Liou JS, et al. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells[J]. Endocrinology, 2001,142(6): 2600-5. [7] Ohashi E, Hong SH, Takahashi T, et al. Effect ofretinoids on growth inhibition of two canine melanoma cell lines[J]. J Vet Med Sci,2001, 63(1): 83-6. [8] Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival[J]. Science, 1998, 281(5381): 1322-26. |